
Publication|Articles|May 1, 2003
The American Journal of Managed Care
- May 2003
- Volume 9
- Issue 5
Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience
Author(s)Darren Kocs, MD, MHSA, A. Mark Fendrick, MD
Advertisement
Articles in this issue
over 22 years ago
Lansoprazole Overutilization: Methods for Step-Down TherapyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Sevabertinib for Nonsquamous NSCLC
2
Medicaid Work Requirements Mirror Programs in Georgia, Arkansas: Ciara Zachary, PhD, MPH
3
Herbal Use Linked to Lower Autoantibodies in Dermatomyositis
4
How Effective and Safe Are GLP-1s for Weight Loss?
5















































